Abstract:Objective To examine the kinetics of plasma S100A12 and soluble receptor for advanced glycation end products (sRAGE) in infants and young children undergoing cardiopulmonary bypass ( CPB),and to investigate whether they could protective the occurrence of noninfectious pulmonary complication (NPC) after cardiac surgery.Methods This was a case-control study.The subjects included all children aged ＜3 years old who underwent cardiac surgery with CPB during the period from June 1st to July 31st 2011.The patient who showed pulmonary inflammation or had abnormal liver or renal function before surgery was excluded.The remain patients were divided into 2 groups according to whether they had developed NPC postoperatively.Twenty patients were grouped into NPC because they developed the complications of pleural effusion,chylothorax,partial lung collapse,pulmonary hypertensive crisis,airway disorders,pneumothorax,pneumomediastinum,or phrenic nerve palsy.Forty patients were categorized into the no-NPC group.Plasma concentrations of S100A12 and sRAGE were measured using ELISA at baseline,before CPB,immediately after CPB,1 h,12 h and 24 h after operation.Differences concentrations between two groups were analyzed with t test.A stepwise logistic regression analysis was used to indentify the independent risk factor for NPC.A P value ＜0.05 was considered statistically significant.Results Plasma levels of S100A12 and sRAGE dramatically increased immediately after CPB ( P ＜ 0.01 ).The levels of sRAGE dropped to lower than baseline level (P ＜0.05),while S100A12 was still at high level 24h after operation (P ＜0.01 ).Levels of S100A12 and sRAGE immediately after CPB in NPC group were significantly higher than the no-NPC group (P ＜ 0.05).Twenty-four hours after operation,levels of S100A12 were still higher in NPC group than no-NPC (P ＜ 0.01 ),while levels of sRAGE were similar in the two groups ( P ＞ 0.05 ).In the stepwise logistic regression analysis,plasma S100A12 level immediately after CPB remained as a independently predictor for postoperative NPC (OR =1.042,95％ CI:1.010 ～ 1.076,P =0.011 ).Levels of S100A12 immediately after CPB were positively associated with mechanical ventilation time ( r =0.47,P ＜ 0.01 ),duration of surgical Intensive Care Unit ( r =0.407,P =0.002) and hospital stay ( r =0.421,P =0.01 ).Conclusions Plasma levels of S100A12 and sRAGE were significantly increased immediately after CPB and the elevated plasma S100A12 immediately after CPB served as an early reliable biomarker of the occurrence and the prognosis of NPC after CPB in infants and young children.

Plasma endothelin-1 and circulating endothelial progenitor cell levels after cardiopulmonary bypass in children with congenital heart diseases: a preliminary study

Levels of Plasma Endothelin-1, Circulating Endothelial Cells, Endothelial Progenitor Cells, and Cytokines after Cardiopulmonary Bypass in Children with Congenital Heart Disease: Role of Endothelin-1 Regulation

Detection of Intercellular Adhesion Molecule-1 during Pediatric Cardiopulmonary Bypass

Levels of plasma endothelin and calcitonin gene-related peptide in children with congenital heart disease and pulmonary hypertension

Studying the association of plasma S100A12 and noninfectious pulmonary complication in infants and young children following cardiopulmonary bypass (HUM1P.305)

[Effect of Cardiopulmonary Bypass on CD11/CD18 Expression of Neutrophils in Children Undergoing Cardiac Surgery].

Studying the Association of Plasma S100a12 and Noninfectious Pulmonary Complication in Infants and Young Children Following Cardiopulmonary Bypass

Age-dependent Mobilization of Circulating Endothelial Progenitor Cells in Infants and Young Children Undergoing Cardiac Surgery with Cardiopulmonary Bypass

The Role of Plasma Gelsolin in Cardiopulmonary Bypass Induced Acute Lung Injury in Infants and Young Children: a Pilot Study

Quantitative and functional changes in platelets and fibrinogen following cardiopulmonary by-pass in children

Plasma Levels of Alarmin HNPs 1–3 Associate with Lung Dysfunction after Cardiac Surgery in Children

The effect of cardiopulmonary bypass on the activation of peripheral T lymphocytes in children under open - heart operation

Application of thromboelastography for children undergoing cardiac surgery with cardiopulmonary bypass

Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children

Apolipoprotein E Levels in Pediatric Patients Undergoing Cardiopulmonary Bypass.

Effects of Heart Bypass Surgery on Plasma Aβ40 and Aβ42 Levels in Infants and Young Children

Effects of Priming Without Plasma During Cardiopulmonary Bypass on Postoperative Recovery and Coagulation Functions of Cyanotic Congenital Heart Diseases in Children

Application of Modified Ultrafiltration on Cardiopulmonary Bypass in Children

Metabolomic profiling of infants undergoing cardiopulmonary bypass and association with clinical outcomes: a systematic review

Changes of cytokines after cardiopulmonary bypass in children with congenital heart disease

Integrated Analysis of Tracheobronchial Fluid from Before and after Cardiopulmonary Bypass Reveals Activation of the Integrated Stress Response and Altered Pulmonary Microvascular Permeability.